Bill Text: MS SB2283 | 2022 | Regular Session | Engrossed


Bill Title: Uniform Controlled Substances Act; revise schedules.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Failed) 2022-03-01 - Died In Committee [SB2283 Detail]

Download: Mississippi-2022-SB2283-Engrossed.html

MISSISSIPPI LEGISLATURE

2022 Regular Session

To: Drug Policy; Judiciary, Division B

By: Senator(s) Jordan, Jackson (11th)

<)amine);

          ( * * *1819)  Pethidine (meperidine);

          ( * * *1920)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;

          ( * * *2021)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;

          ( * * *2122)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;

          ( * * *2223)  Phenazocine;

          ( * * *2324)  Piminodine;

          ( * * *2425)  Racemethorphan;

          ( * * *2526)  Racemorphan;

          ( * * *2627)  Remifentanil;

          ( * * *2728)  Sufentanil;

          ( * * *2829)  Tapentadol;

          ( * * *2930)  Thiafentanil, methyl 4-(2-methoxy-N-phenylacetamido)-1-(2-(thiophen-2-yl)ethyl)

piperidine-4-carboxylate).

     (d)  Stimulants.  Any material, compound, mixture, or preparation which contains any quantity of the following substances:

          (1)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;

          (2)  Phenmetrazine and its salts;

          (3)  Any substance which contains any quantity of methamphetamine, including its salts, isomers, and salts of isomers;

          (4)  Methylphenidate and its salts;

          (5)  Lisdexamfetamine, its salts, isomers and salts of isomers.

     (e)  Depressants.  Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

          (1)  Amobarbital;

          (2)  Secobarbital;

          (3)  Pentobarbital;

          (4)  Glutethimide.

     (f)  Hallucinogenic substances.

          (1)  Dronabinol oral solution [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)];

          (2)  Nabilone [other names include:  (+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo(b,d)pyran-9-one].

     (g)  Immediate precursors.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

          (1)  Amphetamine and methamphetamine immediate precursor:  Phenylacetone (other names include:  phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone);

          (2)  Phencyclidine immediate precursors:

              (i)  1-phenylcyclohexylamine;

               (ii)  1-piperidinocyclohexanecarbonitrile (PCC);

          (3)  Fentanyl immediate precursor:  4-anilino-N-phenethyl-4-piperidine (ANPP).

     (h)  Any material, compound, mixture or preparation which contains any quantity of a Schedule II controlled substance and is listed as an exempt substance in 21 CFR, Section 1308.24 or 1308.32, shall be exempted from the provisions of the Uniform Controlled Substances Law.

     SECTION 3.  Section 41-29-119, Mississippi Code of 1972, is amended as follows:

     41-29-119.  (A)  The controlled substances listed in this section are included in Schedule IV.

                          SCHEDULE IV

          (a)  Narcotic drugs.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains limited quantities of the following narcotic drugs, or any salts thereof:

              (1)  Not more than one (1) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit;

              (2)  Dextropropoxyphene, including its salts (Darvon, Darvon-N; also found in Darvon compound and Darvocet-N, etc.);

              (3)  2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol).

          (b)  Depressants.  Any material, compound, mixture or preparation which contains any quantity of the following substances:

              (1)  Alfaxalone;

              (2)  Alprazolam;

              (3)  Barbital;

               (4)  Brexanolone;

              (5)  Bromazepam;

               (6)  Camazepam;

              (7)  Carisoprodol;

              (8)  Chloral betaine;

              (9)  Chloral hydrate;

              (10)  Chlordiazepoxide and its salts, but does not include chlordiazepoxide hydrochloride and clidinium bromide or chlordiazepoxide and esterified estrogens;

               (11)  Clobazam;

              (12)  Clonazepam;

              (13)  Clorazepate;

              (14)  Clotiazepam;

              (15)  Cloxazolam;

               (16)  Delorazepam;

              (17)  Diazepam;

              (18)  Dichloralphenazone;

              (19)  Estazolam;

               (20)  Ethchlorvynol;

              (21)  Ethinamate;

              (22)  Ethyl loflazepate;

              (23)  Fludiazepam;

              (24)  Flunitrazepam;

              (25)  Flurazepam;

              (26)  Fospropofol;

              (27)  Halazepam;

              (28)  Haloxazolam;

              (29)  Ketazolam;

              (30)  Lemborexant;

              ( * * *3031)  Loprazolam;

              ( * * *3132)  Lorazepam;

               ( * * *3233)  Lormetazepam;

              ( * * *3334)  Mebutamate;

              ( * * *3435)  Medazepam;

              ( * * *3536)  Meprobamate;

              ( * * *3637)  Methohexital;

              ( * * *3738)  Methylphenobarbital;

              ( * * *3839)  Midazolam;

              ( * * *3940)  Nimetazepam;

              ( * * *4041)  Nitrazepam;

              ( * * *4142)  Nordiazepam;

              ( * * *4243)  Oxazepam;

              ( * * *4344)  Oxazolam;

              ( * * *4445)  Paraldehyde;

              ( * * *4546)  Petrichloral;

              ( * * *4647)  Phenobarbital;

              ( * * *4748)  Pinazepam;

              ( * * *4849)  Prazepam;

              ( * * *4950)  Quazepam;

              (51)  Remimazolam;

              ( * * *5052)  Suvorexant;

              ( * * *5153)  Temazepam;

              ( * * *5254)  Tetrazepam;

              ( * * *5355)  Triazolam;

              ( * * *5456)  Zaleplon;

              ( * * *5557)  Zolpidem;

              ( * * *5658)  Zopiclone.

          (c)  Fenfluramine.

          (d)  Lorcaserin.  Any material, compound, mixture, or preparation which contains any quantity of Lorcaserin, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible.

          (e)  Stimulants.  Any material, compound, mixture or preparation which contains any quantity of the following substances:

              (1)  Cathine ((+/-) Norpseudoephedrine);

              (2)  Diethylpropion;

              (3)  Fencamfamin;

              (4)  Fenproporex;

              (5)  Mazindol;

              (6)  Mefenorex;

              (7)  Modafinil;

              (8)  Pemoline (including any organometallic complexes and chelates thereof);

              (9)  Phentermine;

              (10)  Pipradrol;

              (11)  Sibutramine;

              (12)  Solriamfetol;

              (13)  SPA ((-)-1-dimethylamino-1,2-diphenylethane).

          (f)  Other substances.

              (1)  Pentazocine;

              (2)  Butorphanol (including its optical isomers);

              (3)  Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid); (including its optical isomers) and its salts, isomers, and salts of isomers.

     (B)  Any material, compound, mixture or preparation which contains any quantity of a Schedule IV controlled substance and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.

     SECTION 4.  Section 41-29-121, Mississippi Code of 1972, is amended as follows:

     41-29-121.

SCHEDULE V

     (a)  Schedule V consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

     (b)  Narcotic drugs.  [Reserved]

     (c)  Narcotic drugs containing nonnarcotic active medicinal ingredients.  Any compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

          (1)  Not more than two hundred (200) milligrams of codeine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams;

          (2)  Not more than one hundred (100) milligrams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams;

          (3)  Not more than one hundred (100) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams;

          (4)  Not more than two and five-tenths (2.5) milligrams of diphenoxylate and not less than twenty-five (25) micrograms of atropine sulphate per dosage unit;

          (5)  Not more than one hundred (100) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams;

          (6)  Not more than five-tenths (0.5) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit.

     (d)  Stimulants.  Unless specifically excepted or listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substance, including its salts, isomers and salts of isomers:  Pyrovalerone.

     (e)  Depressants.  Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers and salts of isomers:

          (1)  Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact);

          (2)  Cenobamate ([(1R)-1-2-chlorophenyl)-2-tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)

-2-(2H-tetrazol-2-yl)ethyl ester);

          ( * * *23)  Ezogabine [N-[2-amino-4-(4-

fluorobenzylamino)-phenyl]-carbamic acid ethyl ester];

          ( * * *34)  Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide];

          (5)  Lasmiditan [2,4,6-trifluoro-N-(6-

(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide];

          ( * * *46)  Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].

     (f)  Any material, compound, mixture or preparation which contains any quantity of a Schedule V controlled substance and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.

     SECTION 5.  This act shall take effect and be in force from and after July 1, 2022.


feedback